Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security ...
Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
The impacted products have now been given a Class I risk classification by the U.S. Food and Drug Administration.
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
Produce supplier Braga Fresh has issued a ‘precautionary advisory’ about the product, which is no longer in stores but might ...
With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency ...
After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...
Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
The Healthy on MSN3d
FDA Announcement: The First Generic GLP-1 Shot Has Just Been ApprovedThis may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback